Latest Insider Transactions at Cel Sci Corp (CVM)
This section provides a real-time view of insider transactions for Cel Sci Corp (CVM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CEL SCI CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CEL SCI CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 06
2021
|
Robert Eugene Watson Director |
BUY
Open market or private purchase
|
Direct |
1,250
+22.0%
|
$10,000
$8.0 P/Share
|
Jun 30
2021
|
Geert R Kersten Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
501
+0.04%
|
$4,008
$8.68 P/Share
|
Jun 30
2021
|
Patricia B Prichep Sr. VP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
471
+0.23%
|
$3,768
$8.68 P/Share
|
Jun 30
2021
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
276
+0.23%
|
$2,208
$8.68 P/Share
|
Jun 30
2021
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
435
+0.37%
|
$3,480
$8.68 P/Share
|
Jun 28
2021
|
Peter R Young Director |
BUY
Open market or private purchase
|
Direct |
3,000
+9.4%
|
$36,000
$12.66 P/Share
|
Apr 22
2021
|
John Cipriano Senior Vice President |
SELL
Open market or private sale
|
Direct |
10,000
-13.68%
|
$240,000
$24.38 P/Share
|
Mar 31
2021
|
Geert R Kersten Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
285
+0.03%
|
$4,275
$15.21 P/Share
|
Mar 31
2021
|
Patricia B Prichep Sr. VP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
269
+0.13%
|
$4,035
$15.21 P/Share
|
Mar 31
2021
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
157
+0.13%
|
$2,355
$15.21 P/Share
|
Mar 31
2021
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
248
+0.21%
|
$3,720
$15.21 P/Share
|
Dec 31
2020
|
Geert R Kersten Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
366
+0.03%
|
$4,026
$11.66 P/Share
|
Dec 31
2020
|
Patricia B Prichep Sr. VP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
335
+0.16%
|
$3,685
$11.66 P/Share
|
Dec 31
2020
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
205
+0.17%
|
$2,255
$11.66 P/Share
|
Dec 31
2020
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
309
+0.27%
|
$3,399
$11.66 P/Share
|
Dec 11
2020
|
Peter R Young Director |
BUY
Open market or private purchase
|
Direct |
100
+0.38%
|
$1,400
$14.24 P/Share
|
Nov 18
2020
|
Robert Eugene Watson Director |
BUY
Open market or private purchase
|
Direct |
800
+20.1%
|
$8,800
$11.77 P/Share
|
Nov 18
2020
|
Bruno Jean Marie Baillavoine Director |
BUY
Open market or private purchase
|
Direct |
800
+14.48%
|
$8,800
$11.77 P/Share
|
Nov 17
2020
|
Peter R Young Director |
BUY
Open market or private purchase
|
Direct |
800
+3.01%
|
$8,800
$11.68 P/Share
|
Nov 13
2020
|
John Cipriano Senior Vice President |
SELL
Open market or private sale
|
Direct |
10,000
-12.03%
|
$120,000
$12.73 P/Share
|
Nov 04
2020
|
Peter R Young Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+7.4%
|
$22,000
$11.34 P/Share
|
Nov 04
2020
|
Peter R Young Director |
BUY
Open market or private purchase
|
Direct |
1,000
+4.16%
|
$11,000
$11.39 P/Share
|
Sep 30
2020
|
Geert R Kersten Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
335
+0.03%
|
$4,020
$12.75 P/Share
|
Sep 30
2020
|
Patricia B Prichep Sr. VP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
297
+0.14%
|
$3,564
$12.75 P/Share
|
Sep 30
2020
|
Eyal Talor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
188
+0.16%
|
$2,256
$12.75 P/Share
|
Sep 30
2020
|
Daniel H Zimmerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
275
+0.24%
|
$3,300
$12.75 P/Share
|